A mathematical model of erythropoiesis subject to malaria infection is developed by combining ideas from previous models that addressed only one of the two phenomena. The nature of the model allows one to account for suppression of erythropoiesis by the toxin hemozoin, which is a by-product of digested hemoglobin. Following the derivation of the model, numerical simulations are performed and show that the number of parasites produced per bursting erythrocyte has the most significant effect of erythropoiesis. It is also shown that removing hemozoin may be an effective method for aiding the recovery of the erythrocyte population, but is not effective in maintaining a healthy population in the early stages of infection. The second half of the paper introduces an implicit finite difference scheme that was used to perform the simulations previously mentioned. An existence-uniqueness result is then provided via the numerical method.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mbs.2010.02.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Contribution of vitamin B 6 deficiency to anemia in children on regular hemodialysis.
BMC Pediatr
January 2025
Department of Pediatrics, Center of Pediatric Nephrology and Transplantation (CPNT), Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Background: Anemia is prevalent among pediatric patients diagnosed with end-stage kidney disease (ESKD). In addition, erythropoiesis-stimulating agents (ESA) and iron supplementation are considered the cornerstones in the management of anemia. However, a significant proportion of patients remain anemic.
View Article and Find Full Text PDFTris(2-chloroethyl) Phosphate Leads to Unbalanced Circulating Erythrocyte in Mice by Activating both Medullary and Extramedullary Erythropoiesis.
Environ Sci Technol
January 2025
Department of Occupational and Environmental Health, School of Public Health, Qingdao University, Qingdao 266071, China.
Tris(2-chloroethyl) phosphate (TCEP), a prevalent organophosphorus flame retardant, has been identified in various environmental matrices and human blood samples, provoking alarm regarding its hematological toxicity, a subject that has not been thoroughly investigated. Red blood cells (RBCs), or erythrocytes, are the predominant cell type in peripheral blood and are crucial for the maintenance of physiological health. This investigation employed oral gavage to examine the effects of TCEP exposure on erythrocyte counts in mice and to clarify the underlying mechanisms.
View Article and Find Full Text PDFObjectives: This study aimed to determine the frequency of RUNX1/RUNX1T1 gene rearrangement in acute myeloid leukemia (AML) patients by polymerase chain reaction (PCR) and analyze their clinical, hematological, and morphological features of positive patients.
Patients And Methods: A cross-sectional study was conducted in which newly diagnosed patients with AML were included in the study. A total of 101 AML cases were calculated from the World Health Organization (WHO) formula.
Anemia, iron metabolism, and anemia medication habits in patients undergoing maintenance hemodialysis and peritoneal dialysis are different: a multicenter investigation.
Clin Exp Nephrol
December 2024
Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Yishan Road, Shanghai, China.
Background: This study aimed to investigate anemia, iron metabolism status, and treatment in patients undergoing maintenance hemodialysis (HD) and peritoneal dialysis (PD).
Methods: Patients aged ≥ 18 years undergoing HD and PD were surveyed using a case report form to collect information.
Results: Data were collected from 1071 patients undergoing HD and 630 undergoing PD at eight centers.
Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Dialysis-Dependent Patients with Anaemia of Chronic Kidney Disease: A Retrospective Observational Study.
Adv Ther
November 2024
Fresenius Medical Care D GmbH, Bad Homburg, Germany.
Introduction: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in patients with anaemia of chronic kidney disease may lead to increased ESA doses to achieve target haemoglobin levels; however, elevated doses may be associated with increased mortality. Furthermore, patients with hyporesponsiveness to ESAs have poorer clinical outcomes than those who respond well to ESAs. Incidence and clinical characteristics of patients with ESA hyporesponsiveness were explored in a real-world setting.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!